ArticleOncology and therapy2025

Assessing Safety of the Transition to Generic Imatinib in Patients with Gastrointestinal Stromal Tumours.

Joris M van Sabben et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.